founder
pharmaceutical science
syngulon
Belgium
Dr. Philippe Gabant, is one of the founders and the CSO of Syngulon SA. Philippe holds a PhD in Molecular Biology from the Université Libre de Bruxelles (ULB) and a Master in Management de l’Innovation from HEC Saint Louis (Brussels, Belgium). During his academic research career he was involved has an inventor in the development of a portfolio of genetic selection patented technologies. One of these technologies belonging to ULB was licensed to Life technologies in 1995 and is today a standard in molecular biology: Gateway technology, TOPO cloning. Philippe Gabant is one of the founders of Delphi Genetics and the former CEO of the company (2001-2010) he has been in charge of the business development of the company from 2010 and June 2012. Philippe was involved in IP based business agreements including license negotiations and business alliances with major pharmaceutical companies including Sanofi-Pasteur, GSK and Merck.
molecular biololgy mechanism of action of drug